These interactions form a positive feedback loop that drives IGF2BP1 phase separation and promotes c-Myc and E2F1 signaling, cell cycle progression, and proliferation of NSCLC cells (Table 4). The gene discussed is IGF2BP1; the disease is non-small cell lung carcinoma.